Home / Pharma Healthcare / Global Genome Editing/Genome Engineering Sales Market Report to 2021

Global Genome Editing/Genome Engineering Sales Market Report to 2021

  • Id : RNR-23943
  • Category : Pharma Healthcare
  • Publish Date : 12-Oct
  • Pages : 125
  • Format : PDF
License Type

Description
Notes:
Sales, means the sales volume of Genome Editing/Genome Engineering
Revenue, means the sales value of Genome Editing/Genome Engineering

This report studies sales (consumption) of Genome Editing/Genome Engineering in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
    Thermo Fisher Scientific, Inc. (U.S.)
    Merck KGAA (Germany)
    Horizon Discovery Group Plc (U.K.)
    Genscript Biotech Corporation (U.S.)
    Sangamo Biosciences, Inc. (U.S.)
    Integrated DNA Technologies, Inc (U.S.)
    Lonza Group Ltd. (Switzerland)
    New England Biolabs, Inc. (U.S.)
    Origene Technologies, Inc. (U.S.)
    Transposagen Biopharmaceuticals, Inc. (U.S.)
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Genome Editing/Genome Engineering in these regions, from 2011 to 2021 (forecast), like
    USA
    China
    Europe
    Japan
    India
    Southeast Asia
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
    CRISPR
    TALEN
    ZFN
    Antisense
    Other Technologies
Split by applications, this report focuses on sales, market share and growth rate of Genome Editing/Genome Engineering in each application, can be divided into
    Cell Line Engineering
    Animal Genetic Engineering
    Plant Genetic Engineering
    Other Applications